This site contains promotional information intended only for healthcare professionals resident in the United Kingdom

Visit Pfizer Medical siteSearch

Menu

Close

Sign In or RegisterLog Out
Pfizer MedicinesTherapy AreasExplore ContentEventsVideosMaterialsFeatured ArticlesLet’s ConnectSupplyAlliance HealthcareOff-contract claims

Example content

Adverse event reporting can be found at the bottom of the page
Reimagining Intensive Chemotherapy: Intentions and Outcomes

Prescribing information can be found at the bottom of the page.


Join us on 3 April 2025 to hear from Dr Eleni Tholouli, Consultant Haematologist & the Director of Adult Stem Cell Transplant, Cell & Gene Therapy Unit  discussing 'Reimagining Intensive Chemotherapy: Intentions and Outcomes' followed by a live interactive Q&A.

This promotional meeting is organised and funded by Pfizer Ltd for UK HCPs and will include reference to medicines promoted by Pfizer. 

Prescribing information can be found at the bottom of the page.


Join us on 3 April 2025 to hear from Dr Eleni Tholouli, Consultant Haematologist & the Director of Adult Stem Cell Transplant, Cell & Gene Therapy Unit  discussing 'Reimagining Intensive Chemotherapy: Intentions and Outcomes' followed by a live interactive Q&A.

This promotional meeting is organised and funded by Pfizer Ltd for UK HCPs and will include reference to medicines promoted by Pfizer. 

Event Date03 April 2025 12:00 BSTDuration1 Hr AudienceConsultants, Nurses, Pharmacists, Specialist Registrars {{givenName}}%20{{familyName}}%20has%20shared%20a%20resource%20with%20you%3B%20please%20click%20the%20link%20below%3A%0D%0A%0D%0A{{URL}}%0D%0A%0D%0AThank%20you%2C%0D%0A{{givenName}}%20{{familyName}}
Agenda
Meeting Agenda 11:50 - 12:00Joining & Registration
12:00 - 12:05PfizerPro Demonstration Claire Clarke, Pfizer Ltd
12:05 - 12:45Current Thinking of AML Treatments and Management and Patient Case Studies Eleni Tholouli - Dr
12:45 - 13:00Questions & Answers Eleni Tholouli - Dr
13:00Meeting Close
Speakers
Event Speakers
Eleni Tholouli, Dr
Eleni Tholouli, DrConsultant Haematologist & the Director of Adult Stem Cell Transplant, Cell & Gene Therapy Unit, Manchester University NHS Foundation Trust Dr Eleni Tholouli graduated in Germany and completed her haematology specialist training in Manchester where she also undertook a PhD at Manchester University investigating prognostic molecular markers in acute myeloid leukaemia. She consolidated her transplant experience as a Transplant Fellow at the Fred Hutchinson Research Cancer Centre, Seattle, USA, one of the world’s largest transplant centres. Her expertise covers a wide range of haemato-oncological malignancies (leukaemia, myeloma, lymphoma) and non-malignant disorders (bone marrow failures, aplasia). She is the Director of the Adult Stem Cell Transplant and Cell & Gene Therapy Unit. She is the lead for acute leukaemia and a member of the UK AML Research Network Steering Committee and the British Society of Blood and Marrow Transplantation and Cellular Therapy (BSBMTCT).

Mylotarg®(gemtuzumab ozogamicin) 

Prescribing Information

Cytarabine®  

Prescribing Information

Adverse events should be reported. Reporting forms and information can be found at https://yellowcard.mhra.gov.uk or search for MHRA Yellow Card in Google Play or Apple App Store. Adverse events should also be reported to Pfizer Medical Information on 01304 616161.

 PP-MYL-GBR-0994. February 2025

Adverse events should be reported. Reporting forms and information can be found at https://yellowcard.mhra.gov.uk or search 

for MHRA Yellow Card in Google Play or Apple App Store

 

Adverse events should also be reported to Pfizer Medical Information on 01304 616161

PfizerPro Account

To access further materials, resources and receive communication about medicines and vaccines promoted by Pfizer.

Sign In or RegisterAccountSign Out

This site is intended only for healthcare professionals resident in the United Kingdom. If you are a member of the public wishing to access information on a specific medicine, please visit www.medicines.org.uk/emc

 

This website is brought to you by Pfizer Limited, a company registered in England 

and Wales under No. 526209 with its registered office at Ramsgate Road, Sandwich, Kent, CT13 9NJ

 

Copyright © 2025 Pfizer Limited. All rights reserved.

 

VAT registration number GB201048427

PP-UNP-GBR-11245. January 2025
For UK Healthcare Professionals*

These pages are not intended for patients or for members of the general public. The healthcare professional web pages contain promotional content.

I confirm that I am a healthcare professional* resident in the United Kingdom.

If you select 'No', you will be redirected to Pfizer.co.uk where you will be able to access reference information on Pfizer's prescription medicines.

*The ABPI Code definition for healthcare professional is members of the medical, dental, pharmacy and nursing professionals and any other persons who in the course of their professional activities may administer, prescribe, purchase, recommend or supply a medicine.

PP-UNP-GBR-7812. January 2024.

YesNo
You are now leaving PfizerPro​​​​​
​
You are now leaving www.pfizerpro.co.uk. Links to external websites are provided as a resource to the viewer. This website is neither owned or controlled by Pfizer Ltd. 

Pfizer accepts no responsibility for the content or services of the linked site.​​​​​​​​​​​​​​

​​​​​​​PP-PFE-GBR-3858. November 2021​​​​​​​
​​​​​​​
You are now leaving PfizerPro
​​​​​​​
​​​​​​​You are now leaving www.pfizerpro.co.uk. Links to external websites are provided as a resource to the viewer. This website is neither owned nor controlled by Pfizer Ltd. 

Pfizer accepts no responsibility for the content or services of the linked site other than the information or other materials relating to ​​​​​Pfizer medicines or 
business which it has provided or reviewed.

PP-PFE-GBR-3859. November 2021
​​​​​​​